You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
方盛製藥(603998.SH):子公司擬新建方盛康華國際工業園項目 一期項目總投資額約3億元
格隆匯 12-29 16:36

格隆匯 12 月 29日丨方盛製藥(603998.SH)公佈,公司召開第四屆董事會2020年第七次臨時會議,通過關於投資建設湖南方盛康華製藥有限公司基建項目的議案。

董事會同意全資子公司湖南方盛康華製藥有限公司新建方盛康華國際工業園項目,預計項目為12棟建築(工業廠房、倉儲物流房、配套用房等),總建築面積約為216,631㎡,一期項目總投資額約為3億元(含前期購地已支出的5581萬元),該項目由湖南方盛康華製藥有限公司由自籌資金解決(包括但不限於對外融資等,若涉及抵押貸款、擔保融資及引入合作方共同開發等事項則需另行審批);要求承包單位具備建設行政主管部門核發的建築工程施工總承包貳級(含)以上資質,須具有有效的施工企業《安全生產許可證》,並通過公司公開招投標方式獲得承包權益。在上述工程造價預算範圍以內,授權董事長張慶華全權處理。

上述項目已經在長沙市高新區行政審批服務局辦理了備案手續。此次基建項目的相關定價以長沙市工程計價相關規定為依據,不會損害公司及股東的利益。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account